Table 1 |
|||||
|
Antibodies used for immunohistochemical staining |
|||||
| Factor |
Antibody |
Companya |
Dilution |
Scoring |
Cutoff |
|
|
|||||
| HER2 |
NCL-CB 11 |
Novocastra |
1:40 |
0, 1, 2, 3 |
≥ 2+ |
| Top IIa |
Ab1, clone SWT3D1 |
Oncogene |
1:40 |
% stained cells |
>10% |
| Ki 67 |
Ki 67, clone MIB-1 |
Dako |
1:100 |
% stained cells |
>0% |
| p53 |
p53, clone DO-7 |
Dako |
1:200 |
% stained cells |
>5% |
|
|
|||||
|
HER2, human epithelial growth factor receptor 2; Top IIa, topoisomerase IIα. aNovocastra, Newcastle upon Tyne, UK; Oncogene, Cambridge, MA, USA; DAKO, Hamburg, Germany |
|||||
|
Schindlbeck et al. Breast Cancer Research 2005 7:R1174 doi:10.1186/bcr1360 |
|||||